OBJECTIVE: Higher than normal body mass index (BMI) is associated with an increased risk of death in the general population. We examined the effect of higher than normal BMI on patient and technique survival in peritoneal dialysis patients (PD), controlling for comorbidity, initial albumin, dialysate-to-plasma ratio of creatinine (D/P(Cr)), and initial urea clearance (Kt/V). DESIGN: Registry database. SETTINGS: Four dialysis centers. PATIENTS: Incident PD patients. METHODS: All data were collected prospectively. Demographics, BMI, serum albumin, D/P(Cr), and comorbidity using the Charlson Comorbidity Index (CCI) were determined at the start of PD. 104 patients with a high BMI (> 27) were matched to a control group of 104 patients with normal BMI (20-27) for age, gender, presence of diabetes, and CCI. Patient and technique survival were compared using Cox proportional hazards model. MAIN OUTCOME MEASURES: Patient and technique survival. RESULTS: The groups were of similar age (56.1 vs 56.7 years), sex (60% males in both groups), race (Caucasian 80% vs 86%), presence of diabetes (40% vs 37%), CCI score (5.4 in both groups), initial albumin (3.6 vs 3.5 g/dL), and D/P(Cr) (0.65 in both groups). Kaplan-Meier survival analysis showed similar 2-year patient survival between large BMI (> 27) and control (20-27) groups (76.6% vs 76.1%). Two-year technique survival was also similar between the two groups (59.7% vs 66.8%). With Cox proportional hazards analysis, BMI was not a predictor of patient mortality or technique survival when controlling for initial albumin, D/P(Cr), and initial Kt/V. CONCLUSIONS: We conclude that a BMI above normal is not associated with any increased or decreased risk of death in patients on PD for 2 years.

This article has been cited by other articles:

				O. Khawar, K. Kalantar-Zadeh, W. K. Lo, D. Johnson, and R. Mehrotra Is the Declining Use of Long-Term Peritoneal Dialysis Justified by Outcome Data? Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1317 - 1328. [Abstract] [Full Text] [PDF]

				D. Schmidt and A. Salahudeen The Obesity-Survival Paradox in Hemodialysis Patients: Why Do Overweight Hemodialysis Patients Live Longer? Nutr Clin Pract, February 1, 2007; 22(1): 11 - 15. [Abstract] [Full Text] [PDF]

				X. Wang, J. Axelsson, L. Nordfors, A. R. Qureshi, C. Avesani, P. Barany, M. Schalling, O. Heimburger, B. Lindholm, and P. Stenvinkel Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism Nephrol. Dial. Transplant., January 1, 2007; 22(1): 196 - 202. [Abstract] [Full Text] [PDF]

				K. S. Brimble, M. Walker, P. J. Margetts, K. K. Kundhal, and C. G. Rabbat Meta-Analysis: Peritoneal Membrane Transport, Mortality, and Technique Failure in Peritoneal Dialysis J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2591 - 2598. [Abstract] [Full Text] [PDF]

				K. Kalantar-Zadeh, K. C Abbott, A. K Salahudeen, R. D Kilpatrick, and T. B Horwich Survival advantages of obesity in dialysis patients Am. J. Clinical Nutrition, March 1, 2005; 81(3): 543 - 554. [Abstract] [Full Text] [PDF]

				S. P. McDonald, J. F. Collins, and D. W. Johnson Obesity Is Associated with Worse Peritoneal Dialysis Outcomes in the Australia and New Zealand Patient Populations J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2894 - 2901. [Abstract] [Full Text] [PDF]

				A. K. Salahudeen Is it really good to be fat on dialysis? Nephrol. Dial. Transplant., July 1, 2003; 18(7): 1248 - 1252. [Full Text] [PDF]

Copyright © 2002 by Multimed Inc.